论文部分内容阅读
目的:观察痰热清注射液治疗婴幼儿毛细支气管炎的临床疗效。方法:将治疗的41例毛细支气管炎婴幼儿分为治疗组21例和对照组20例;治疗组患者在常规治疗的基础上加用痰热清注射液雾化吸入辅助治疗,对照组患者给予常规治疗;分析比较两组患者的临床疗效。结果:治疗组患者总有效率为93.73%,对照组76.67%,经比较其差异有统计学意义(P<0.05);其中治疗组患者喘憋消失时间、哮鸣音消失时间、住院天数分别为(1.56±1.12)d、(5.52±1.48)d、(6.80±1.50)d,而对照组患者分别为(7.81±2.51)d、(9.17±3.24)d、(9.43±3.64)d均高于治疗组,经比较其差异有统计学意义(P<0.01)。结论:用痰热清注射液雾化吸入辅助治疗毛细支气管炎,疗效显著,能缩短患者的住院时间。
Objective: To observe the clinical efficacy of Tanreqing Injection in the treatment of infantile bronchiolitis. Methods: The treatment of 41 cases of bronchiolitis infants and young children were divided into treatment group 21 cases and control group 20 cases; treatment group patients on the basis of conventional treatment with Tanreqing injection nebulization inhalation therapy, patients in the control group Routine treatment; analysis of clinical efficacy of two groups of patients. Results: The total effective rate was 93.73% in the treatment group and 76.67% in the control group, and the difference was statistically significant (P <0.05). The disappearance time of wheezing, disappearance of wheeze and hospital stay in the treatment group were (1.56 ± 1.12) d, (5.52 ± 1.48) d and (6.80 ± 1.50) d respectively, while those in the control group were (7.81 ± 2.51) days and (9.17 ± 3.24 days), respectively The treatment group, the difference was statistically significant (P <0.01). Conclusion: The treatment of bronchiolitis with atomization inhalation of Tanreqing Injection has significant curative effect, which can shorten the hospitalization time of patients.